Carvedilol, USP (United States Pharmacopeia), is a non-selective beta-adrenergic blocker with alpha-1 blocking activity. It is used primarily in the management of hypertension and heart failure. The medication works by relaxing blood vessels and slowing heart rate, which helps to lower blood pressure and reduce the workload on the heart. Carvedilol is available in various dosage forms, including tablets, and is recognized for its antioxidant properties, contributing to its cardioprotective effects. The USP monograph provides specifications for the drug’s identity, strength, quality, and purity to ensure consistency and safety in manufacturing and quality control.
Identification: Confirmed by methods such as thin-layer chromatography (TLC) and infrared (IR) spectroscopy to verify the chemical identity of Carvedilol.
Assay (Content): The active ingredient content must be within a specified range, usually 98.0% to 102.0% of the labeled amount, determined by an appropriate assay method such as HPLC.
Impurities:
Related Substances: Limits are set for unspecified and specified impurities, generally not exceeding 0.5% for each impurity and 2.0% for total impurities.
Residual Solvents: Must comply with ICH guidelines, with acceptable levels for solvents like methanol, ethanol, etc.
Loss on Drying: Usually not more than 0.5% to 1.0%, indicating the moisture content.
Residue on Ignition: Not more than a specified percentage (e.g., 0.1%) to account for inorganic impurities.
Physical Characteristics:
Appearance: Usually a white or off-white crystalline powder.
Melting Point: Typically within a specific temperature range.
Microbial Limits: The product must meet specified limits for total aerobic microbial count and absence of specific pathogens.
Packaging and Storage: Must be stored in well-closed containers protected from light and moisture.
Reviews
There are no reviews yet.
Be the first to review “Carvedilol, USP” Cancel reply
Reviews
There are no reviews yet.